@DrSethdb
www.nejm.org Long-Term Outcomes of the DanGer Shock Trial | NEJM In patients with STEMI with cardiogenic shock, early mechanical support with a microaxial pump reduced the risk of death at 180 days, with the survival benefit persisting up to 10 years despite dev... 
Congratulations to Dr. Jacob Møller and colleagues for today's #ESCCongress 2025 late breaking clinical science data and @NEJM publication of long-term data from the DanGer Shock RCT confirming the long-term survival benefit of the Impella CP heart pumpView quoted post on X
73y man, DM2, severe PVD admitted w/ decomp HF. Cardiac MR with EF:30%, large antero-lat ischemia and inf fibrosis. CAG: RCA CTO, calcified nodule LM and severe IRS ostial LAD+CX. @ProtectedPCI w/ Impella CP via right axilar art. IVL LM + LM/LAD stent + KB + POT + DEB ostial CXView quoted post on X
#Impella CP & single access
Rota 1.5 burr LM into LAD
Wolverine 3.5 to LCx
Minicrush
IVUS -> POT, Kiss, POT
@evandrofilhobr @DhavalDesaiMD @willsuh76 @FrederickWelt @chadialraies @DrChuckSimonton @DrSethdb @sbrugaletta @AntoniousAttall @atunuguntla1 @SrihariNaiduMD @nishheartdocView quoted post on X
